
Pharma Pulse 10/2/24: Creating a Digitized Supply Chain, Factors to Consider When Switching Therapies & more
The latest news for pharma industry insiders.
In the third part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, details the importance of E2E visibility.
The discussion covers when to consider transitioning to a new therapeutic option in CLL and the factors that influence the decision between dose modification and switching therapies.
Casey reports back from a wild day at Meta Connect, discussing what’s new with Meta’s efforts in artificial intelligence, virtual reality headsets and the Holy Grail — augmented reality glasses. Then, Steven Johnson, a writer and editorial director at Google Labs, stops by to talk about the company’s new hit NotebookLM, which uses A.I. to turn even boring PDFs, such as user manuals and Kevin’s bank records, into chatty, disturbingly good podcasts. Finally, so much happened in tech news this week that we reached for the bucket hat in the latest installment of HatGPT!
Humana is also supporting its members across the affected areas by providing simplified access to medical and emergency prescription information, as well as opening a crisis hotline with free counseling available.
Join industry leaders from McKesson Third Party Logistics℠ for an insightful discussion on DSCSA compliance. Don’t miss out—register below!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

